April 4, 2018 / 7:11 AM / 6 months ago

BRIEF-Hebei Changshan Biochemical Pharmaceutical sees FY 2018 Q1 net profit could rise up to 10 pct

April 4 (Reuters) - Hebei Changshan Biochemical Pharmaceutical Co Ltd

* Says it sees FY 2018 Q1 net profit to increase by up to 10 percent, or to be 43 million yuan to 47.3 million yuan

* Says FY 2017 Q1 net profit was 43 million yuan

* Comments that increased income from heparin water needle preparation and heparin crude drug as main reasons for the forecast

Source text in Chinese:goo.gl/i6xmtF

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below